CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A

被引:21
|
作者
Fukami, T.
Nakajima, M. [1 ]
Sakai, H.
McLeod, H. L.
Yokoi, T.
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Dept Drug Metab & toxicol, Kanazawa, Ishikawa 920, Japan
[2] Washington Univ, Dept Med, St Louis, MO 63130 USA
来源
PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 06期
关键词
CYP2A6; CYP2A7; deletion allele; genetic polymorphism;
D O I
10.1038/sj.tpj.6500390
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Human cytochrome P450 (CYP) 2A6 metabolizes nicotine to cotinine. Genetic polymorphisms of CYP2A6 contribute to the interindividual variability of nicotine metabolism. We encountered some subjects possessing two copies of the CYP2A6 gene, although they were genotyped as heterozygotes of the CYP2A6*4A allele ( entire CYP2A6 gene deleted allele). From the subjects, we found CYP2A7 polymorphic alleles (CYP2A7*1B, CYP2A7*1C, and CYP2A7*1D) in which the sequences in the 3'-flanking region were converted to the corresponding CYP2A6 sequences, being confused with the CYP2A6*4A. These allele frequencies in European-Americans (n = 187) were 1.3, 2.1, 0.3%, respectively, but these were very rare in African-Americans (n = 176), Japanese (n = 184), and Koreans ( n 209). By an improved genotyping method, the allele frequency of CYP2A6*4A of 3.7% in European-Americans was corrected to 0%. The comprehensible and reliable genotyping method developed in this study would be useful to evaluate associations between the genotype and phenotype.
引用
收藏
页码:401 / 412
页数:12
相关论文
共 50 条
  • [1] CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele
    T Fukami
    M Nakajima
    H Sakai
    H L McLeod
    T Yokoi
    [J]. The Pharmacogenomics Journal, 2006, 6 : 401 - 412
  • [2] Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity
    Oscarson, M
    McLellan, RA
    Asp, V
    Ledesma, M
    Ruiz, MLB
    Sinues, B
    Rautio, A
    Ingelman-Sundberg, M
    [J]. HUMAN MUTATION, 2002, 20 (04) : 275 - 283
  • [3] Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity
    Fukami, T
    Nakajima, M
    Higashi, E
    Yamanaka, H
    Sakai, H
    McLeod, HL
    Yokoi, T
    [J]. DRUG METABOLISM AND DISPOSITION, 2005, 33 (08) : 1202 - 1210
  • [4] A pilot study characterizing two novel CYP2A6 alleles, CYP2A6*7 and CYP2A6*8, in vivo.
    Xu, C
    Rao, Y
    Xu, B
    Hoffmann, E
    Sellers, EM
    Tyndale, RF
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P35 - P35
  • [5] Novel human CYP2A6 alleles confound gene deletion analysis
    Nakajima, M
    Yoshida, R
    Fukami, T
    McLeod, HL
    Yokoi, T
    [J]. FEBS LETTERS, 2004, 569 (1-3): : 75 - 81
  • [6] High prevalence of CYP2A6*4 and CYP2A6*9 alleles detected among a Malaysian population
    Yusof, Wardah
    Gan, Siew Hua
    [J]. CLINICA CHIMICA ACTA, 2009, 403 (1-2) : 105 - 109
  • [7] Genotyping human CYP2A6 variants
    Goodz, SD
    Tyndale, RF
    [J]. CYTOCHROME P450, PT C, 2002, 357 : 59 - 69
  • [8] Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method
    Mwenifumbo, JC
    Myers, MG
    Wall, TL
    Lin, SK
    Sellers, EM
    Tyndale, RF
    [J]. PHARMACOGENETICS AND GENOMICS, 2005, 15 (03): : 189 - 192
  • [9] CYP2A7 Pseudogene Transcript Affects CYP2A6 Expression in Human Liver by Acting as a Decoy for miR-126☆
    Nakano, Masataka
    Fukushima, Yasunari
    Yokota, Shin-ichi
    Fukami, Tatsuki
    Takamiya, Masataka
    Aoki, Yasuhiro
    Yokoi, Tsuyoshi
    Nakajima, Miki
    [J]. DRUG METABOLISM AND DISPOSITION, 2015, 43 (05) : 703 - 712
  • [10] Genotyping and phenotyping of the coumarin 7-hydroxylase CYP2A6 in man
    Bourian, M
    Runkel, M
    Freudenstein, J
    Tegtmeier, M
    Legrum, W
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R170 - R170